Schmid, P. Et Al. 2020. Pembrolizumab for Early Triple-Negative Breast Cancer. NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.9 , 810-821.

Schmid, P., Cortes, J., Pusztai, L., McArthur, H., Kuemmel, S., Bergh, J., ... Denkert, C.(2020). Pembrolizumab for Early Triple-Negative Breast Cancer. NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.9, 810-821.

Schmid, Peter Et Al. "Pembrolizumab for Early Triple-Negative Breast Cancer," NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.9, 810-821, 2020

Schmid, Peter Et Al. "Pembrolizumab for Early Triple-Negative Breast Cancer." NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.9, pp.810-821, 2020

Schmid, P. Et Al. (2020) . "Pembrolizumab for Early Triple-Negative Breast Cancer." NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.9, pp.810-821.

@article{article, author={Peter Schmid Et Al. }, title={Pembrolizumab for Early Triple-Negative Breast Cancer}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2020, pages={810-821} }